Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antitumor titanium compounds.

Francesco Caruso1, Miriam Rossi

  • 1Instituto di Chimica Biomolecolare, Consiglio Nazionale delle Ricerche, Piazzale Aldo Moro, 5 00185, Rome, Italy. francesco.caruso@icb.cnr.it

Mini Reviews in Medicinal Chemistry
|February 3, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An open-access dataset of odontocete acoustic signals from the Madeira archipelago.

Scientific data·2026
Same author

Acoustic characterization of sperm whale (Physeter macrocephalus) population structure and social organization in the South China Sea.

The Journal of the Acoustical Society of America·2026
Same author

Preliminary characterization of underwater noise from a salmon farm in northern Patagonia.

Marine pollution bulletin·2026
Same author

Seminal plasma concentrations of long-acting cabotegravir in men receiving HIV pre-exposure prophylaxis.

Antimicrobial agents and chemotherapy·2026
Same author

Identification and classification of repeated whistle types from free-ranging rough-toothed dolphins (Steno bredanensis).

Scientific reports·2026
Same author

A wave glider for passive acoustic monitoring of cetaceans and anthropogenic sources in the central Mediterranean Sea.

Scientific reports·2025
Same journal

PROTAC-Mediated Targeting of PARP via CRBN: Mechanistic Insights, Resistance Challenges, and Therapeutic Advancements.

Mini reviews in medicinal chemistry·2026
Same journal

Recent Advancements in the Development of Heterocyclic Scaffolds as Potential Anti-cancer Agents Targeting EGFR and VEGFR-2.

Mini reviews in medicinal chemistry·2026
Same journal

Exploring the Anticancer Potential of Synthetic β-Carboline Derivatives: A Comprehensive Systematic Review.

Mini reviews in medicinal chemistry·2026
Same journal

KIF20A in Human Malignancies: Oncogenic Mechanisms and Therapeutic Targeting Strategies.

Mini reviews in medicinal chemistry·2026
Same journal

Phytocompound-loaded Biomaterial-based Scaffolds: Emerging Strategies for Wound Healing Applications.

Mini reviews in medicinal chemistry·2026
Same journal

Bioprospecting of Natural Products as Sources of New Multitarget Therapies.

Mini reviews in medicinal chemistry·2026
See all related articles

Titanium compounds show anticancer activity, particularly for gastrointestinal tumors, with fewer side effects than traditional chemotherapy. Further research into titanocene dichloride and budotitane is promising for cancer treatment.

Area of Science:

  • Medicinal Chemistry
  • Oncology
  • Materials Science

Background:

  • Titanium compounds exhibit anticancer properties, primarily targeting gastrointestinal tumors.
  • Some titanium compounds also show efficacy against breast, lung, and melanoma cancers.
  • A key advantage is their lack of common chemotherapy side effects like nausea, hair loss, or bone marrow damage.

Purpose of the Study:

  • To review titanium-based anticancer drugs, focusing on titanocene dichloride and budotitane.
  • To explore the biological fate and structure-activity relationships of Ti-cyclopentadienyl and Ti-beta-diketonato compounds.
  • To discuss novel titanium species with enhanced solubility and polynuclear structures for improved drug delivery and efficacy.

Main Methods:

  • Literature review of titanium compounds in cancer therapy.

Related Experiment Videos

  • Analysis of clinical trial data for titanocene dichloride and budotitane.
  • Structure-activity relationship studies of titanium-based anticancer agents.

    • Main Results:

    • Titanium compounds demonstrate significant anticancer potential with a favorable side effect profile.
    • Titanocene dichloride and budotitane have advanced to clinical trials.
    • Novel titanium derivatives show promise for improved drug delivery and therapeutic outcomes.

    Conclusions:

    • Titanium compounds represent a promising class of anticancer agents, suitable for combination therapies.
    • Further investigation into their biological fate and structure-activity relationships is warranted.
    • Development of novel titanium-based drugs with enhanced solubility and polynuclear structures could lead to more effective cancer treatments.